{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T03:28:46Z","timestamp":1792639726236,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2012,2,2]],"date-time":"2012-02-02T00:00:00Z","timestamp":1328140800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2012,9]]},"DOI":"10.1007\/s00415-012-6428-3","type":"journal-article","created":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T16:22:51Z","timestamp":1328113371000},"page":"1769-1780","source":"Crossref","is-referenced-by-count":86,"title":["Positron emission tomography imaging in neurological disorders"],"prefix":"10.1007","volume":"259","author":[{"given":"Marios","family":"Politis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Piccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,2,2]]},"reference":[{"key":"6428_CR1","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3109\/03091908709008988","volume":"11","author":"C Birattari","year":"1987","unstructured":"Birattari C, Bonardi M, Ferrari A, Milanesi L, Silari M (1987) Biomedical applications of cyclotrons and review of commercially available models. J Med Eng Technol 11:166\u2013176","journal-title":"J Med Eng Technol"},{"key":"6428_CR2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0001-2998(77)80042-1","volume":"7","author":"ME Phelps","year":"1977","unstructured":"Phelps ME (1977) Emission computed tomography. Semin Nucl Med 7:337\u2013365","journal-title":"Semin Nucl Med"},{"key":"6428_CR3","doi-asserted-by":"crossref","first-page":"9226","DOI":"10.1073\/pnas.97.16.9226","volume":"97","author":"ME Phelps","year":"2000","unstructured":"Phelps ME (2000) Positron emission tomography provides molecular imaging of biological processes. PNAS 97:9226\u20139233","journal-title":"PNAS"},{"key":"6428_CR4","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1038\/jcbfm.1993.81","volume":"13","author":"SR Cherry","year":"1993","unstructured":"Cherry SR, Woods RP, Hoffman EJ, Mazziotta JC (1993) Improved detection of focal cerebral blood flow changes using three-dimensional positron emission tomography. J Cereb Blood Flow Metab 13:630\u2013638","journal-title":"J Cereb Blood Flow Metab"},{"key":"6428_CR5","first-page":"1614","volume":"38","author":"G Brix","year":"1997","unstructured":"Brix G, Zaers J, Adam LE, Bellemann ME, Ostertag H, Trojan H, Haberkorn U, Doll J, Oberdorfer F, Lorenz WJ (1997) Performance evaluation of a whole-body PET scanner using the NEMA protocol. National Electrical Manufacturers Association. J Nucl Med 38:1614\u20131623","journal-title":"J Nucl Med"},{"key":"6428_CR6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1088\/0031-9155\/45\/9\/313","volume":"45","author":"TJ Spinks","year":"2000","unstructured":"Spinks TJ, Jones T, Bloomfield PM, Bailey DL, Miller M, Hogg D, Jones WF, Vaigneur K, Reed J, Young J, Newport D, Moyers C, Casey ME, Nutt R (2000) Physical characteristics of the ECAT EXACT3D positron tomograph. Phys Med Biol 45:2601\u20132618","journal-title":"Phys Med Biol"},{"key":"6428_CR7","first-page":"1960","volume":"47","author":"BJ Kemp","year":"2006","unstructured":"Kemp BJ, Kim C, Williams JJ, Ganin A, Lowe VJ, National Electrical Manufacturers Association (NEMA) (2006) NEMA NU 2\u20132001 performance measurements of an LYSO-based PET\/CT system in 2D and 3D acquisition modes. J Nucl Med 47:1960\u20131967","journal-title":"J Nucl Med"},{"key":"6428_CR8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/ana.10526","volume":"53","author":"P Piccini","year":"2003","unstructured":"Piccini P, Pavese N, Brooks DJ (2003) Endogenous dopamine release after pharmacological challenges in Parkinson\u2019s disease. Ann Neurol 53:647\u2013665","journal-title":"Ann Neurol"},{"key":"6428_CR9","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1093\/brain\/awh290","volume":"127","author":"R Fuente-Fern\u00e1ndez de la","year":"2004","unstructured":"de la Fuente-Fern\u00e1ndez R, Sossi V, Huang Z, Furtado S, Lu JQ, Calne DB, Ruth TJ, Stoessl AJ (2004) Levodopa-induced changes in synaptic dopamine levels increase with progression of Parkinson\u2019s disease: implications for dyskinesias. Brain 127:2747\u20132754","journal-title":"Brain"},{"key":"6428_CR10","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1002\/1531-8249(200011)48:5<689::AID-ANA1>3.0.CO;2-N","volume":"48","author":"P Piccini","year":"2000","unstructured":"Piccini P, Lindvall O, Bj\u00f6rklund A, Brundin P, Hagell P, Ceravolo R, Oertel W, Quinn N, Samuel M, Rehncrona S, Widner H, Brooks DJ (2000) Delayed recovery of movement-related cortical function in Parkinson\u2019s disease after striatal dopaminergic grafts. Ann Neurol 48:689\u2013695","journal-title":"Ann Neurol"},{"key":"6428_CR11","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1093\/brain\/awn054","volume":"131","author":"N Sawamoto","year":"2008","unstructured":"Sawamoto N, Piccini P, Hotton G, Pavese N, Thielemans K, Brooks DJ (2008) Cognitive deficits and striato-frontal dopamine release in Parkinson\u2019s disease. Brain 131:1294\u20131302","journal-title":"Brain"},{"key":"6428_CR12","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/brain\/awg035","volume":"126","author":"IK Goerendt","year":"2003","unstructured":"Goerendt IK, Messa C, Lawrence AD, Grasby PM, Piccini P, Brooks DJ, PET study (2003) Dopamine release during sequential finger movements in health and Parkinson\u2019s disease: a PET study. Brain 126:312\u2013325","journal-title":"Brain"},{"key":"6428_CR13","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1038\/sj.jcbfm.9600493","volume":"27","author":"RB Innis","year":"2007","unstructured":"Innis RB, Cunningham VJ, Delforge J, Fujita M, Gjedde A, Gunn RN, Holden J, Houle S, Huang SC, Ichise M, Iida H, Ito H, Kimura Y, Koeppe RA, Knudsen GM, Knuuti J, Lammertsma AA, Laruelle M, Logan J, Maguire RP, Mintun MA, Morris ED, Parsey R, Price JC, Slifstein M, Sossi V, Suhara T, Votaw JR, Wong DF, Carson RE (2007) Consensus nomenclature for in vivo imaging of reversibly binding radioligands. J Cereb Blood Flow Metab 27:1533\u20131539","journal-title":"J Cereb Blood Flow Metab"},{"key":"6428_CR14","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1006\/nimg.1996.0066","volume":"4","author":"AA Lammertsma","year":"1996","unstructured":"Lammertsma AA, Hume SP (1996) Simplified reference tissue model for PET receptor studies. Neuroimage 4:153\u2013158","journal-title":"Neuroimage"},{"key":"6428_CR15","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1006\/nimg.1997.0303","volume":"6","author":"RN Gunn","year":"1997","unstructured":"Gunn RN, Lammertsma AA, Hume SP, Cunningham VJ (1997) Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 6:279\u2013287","journal-title":"Neuroimage"},{"key":"6428_CR16","first-page":"1936","volume":"47","author":"AJ Montgomery","year":"2006","unstructured":"Montgomery AJ, Thielemans K, Mehta MA, Turkheimer F, Mustafovic S, Grasby PM (2006) Correction of head movement on PET studies: comparison of methods. J Nucl Med 47:1936\u20131944","journal-title":"J Nucl Med"},{"key":"6428_CR17","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/305137a0","volume":"305","author":"ES Garnett","year":"1983","unstructured":"Garnett ES, Firnau G, Nahmias C (1983) Dopamine visualized in the basal ganglia of living man. Nature 305:137\u2013138","journal-title":"Nature"},{"key":"6428_CR18","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1002\/ana.410410111","volume":"41","author":"FJ Vingerhoets","year":"1997","unstructured":"Vingerhoets FJ, Schulzer M, Calne DB, Snow BJ (1997) Which clinical sign of Parkinson\u2019s disease best reflects the nigrostriatal lesion? Ann Neurol 41:58\u201364","journal-title":"Ann Neurol"},{"key":"6428_CR19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0022-510X(99)00127-6","volume":"166","author":"E Broussolle","year":"1999","unstructured":"Broussolle E, Dentresangle C, Landais P, Garcia-Larrea L, Pollak P, Croisile B, Hibert O, Bonnefoi F, Galy G, Froment JC, Comar D (1999) The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson\u2019s disease. J Neurol Sci 166:141\u2013151","journal-title":"J Neurol Sci"},{"key":"6428_CR20","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1093\/brain\/114.5.2283","volume":"114","author":"JM Fearnley","year":"1991","unstructured":"Fearnley JM, Lees AJ (1991) Ageing and Parkinson\u2019s disease: substantia nigra regional selectivity. Brain 114:2283\u20132301","journal-title":"Brain"},{"key":"6428_CR21","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1002\/mds.22484","volume":"24","author":"A Br\u00fcck","year":"2009","unstructured":"Br\u00fcck A, Aalto S, Rauhala E, Bergman J, Marttila R, Rinne JO (2009) A follow-up study on 6-[18F] fluoro-l-dopa uptake in early Parkinson\u2019s disease shows nonlinear progression in the putamen. Mov Disord 24:1009\u20131015","journal-title":"Mov Disord"},{"key":"6428_CR22","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1001\/archneur.62.3.378","volume":"62","author":"R Hilker","year":"2005","unstructured":"Hilker R, Schweitzer K, Coburger S, Ghaemi M, Weisenbach S, Jacobs AH, Rudolf J, Herholz K, Heiss WD (2005) Nonlinear progression of Parkinson disease as determined by serial positron emission tomographic imaging of striatal fluorodopa F 18 activity. Arch Neurol 62:378\u2013382","journal-title":"Arch Neurol"},{"key":"6428_CR23","doi-asserted-by":"crossref","first-page":"2970","DOI":"10.1093\/brain\/awp209","volume":"132","author":"R Nandhagopal","year":"2009","unstructured":"Nandhagopal R, Kuramoto L, Schulzer M, Mak E, Cragg J, Lee CS, McKenzie J, McCormick S, Samii A, Troiano A, Ruth TJ, Sossi V, de la Fuente-Fernandez R, Calne DB, Stoessl AJ (2009) Longitudinal progression of sporadic Parkinson\u2019s disease: a multi-tracer positron emission tomography study. Brain 132:2970\u20132979","journal-title":"Brain"},{"key":"6428_CR24","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1002\/1531-8249(200004)47:4<493::AID-ANA13>3.0.CO;2-4","volume":"47","author":"CS Lee","year":"2000","unstructured":"Lee CS, Samii A, Sossi V, Ruth TJ, Schulzer M, Holden JE, Wudel J, Pal PK, de la Fuente Fernandez R, Calne DB, Stoessl AJ (2000) In vivo positron emission tomographic evidence for compensatory changes in presynaptic dopaminergic nerve terminals in Parkinson\u2019s disease. Ann Neurol 47:493\u2013503","journal-title":"Ann Neurol"},{"key":"6428_CR25","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/syn.20653","volume":"63","author":"R Fern\u00e1ndez Fuente de la","year":"2009","unstructured":"de la Fern\u00e1ndez Fuente R, Sossi V, McCormick S, Schulzer M, Ruth TJ, Stoessl AJ (2009) Visualizing vesicular dopamine dynamics in Parkinson\u2019s disease. Synapse 63:713\u2013716","journal-title":"Synapse"},{"key":"6428_CR26","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1001\/archneur.1990.00530120034007","volume":"47","author":"KL Leenders","year":"1990","unstructured":"Leenders KL, Salmon EP, Tyrrell P, Perani D, Brooks DJ, Sager H, Jones T, Marsden CD, Frackowiak RS (1990) The nigrostriatal dopaminergic system assessed in vivo by positron emission tomography in healthy volunteer subjects and patients with Parkinson\u2019s disease. Arch Neurol 47:1290\u20131298","journal-title":"Arch Neurol"},{"key":"6428_CR27","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/jcbfm.1990.59","volume":"10","author":"E Salmon","year":"1990","unstructured":"Salmon E, Brooks DJ, Leenders KL, Turton DR, Hume SP, Cremer JE, Jones T, Frackowiak RS (1990) A two-compartment description and kinetic procedure for measuring regional cerebral [11C]nomifensine uptake using positron emission tomography. J Cereb Blood Flow Metab 10:307\u2013316","journal-title":"J Cereb Blood Flow Metab"},{"key":"6428_CR28","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0404.1990.tb00926.x","volume":"81","author":"J Tedroff","year":"1990","unstructured":"Tedroff J, Aquilonius SM, Laihinen A, Rinne U, Hartvig P, Anderson J, Lundqvist H, Haa paranta M, Solin O, Antoni G, Gee AD, Ullin J, L\u00e5ngstr\u00f6m B (1990) Striatal kinetics of [11C]-(+)- nomifensine and 6-[18F]fluoro-L-dopa in Parkinson\u2019s disease measured with positron emission tomography. Acta Neurol Scand 81:24\u201330","journal-title":"Acta Neurol Scand"},{"key":"6428_CR29","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410340331","volume":"34","author":"JJ Frost","year":"1993","unstructured":"Frost JJ, Rosier AJ, Reich SG, Smith JS, Ehlers MD, Snyder SH, Ravert HT, Dannals RF (1993) Positron emission tomographic imaging of the dopamine transporter with 11C-WIN 35,428 reveals marked declines in mild Parkinson\u2019s disease. Ann Neurol 34:423\u2013431","journal-title":"Ann Neurol"},{"key":"6428_CR30","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/BF02252963","volume":"9","author":"RM Mari\u00e9","year":"1995","unstructured":"Mari\u00e9 RM, Barr\u00e9 L, Rioux P, Allain P (1995) Lecheva- lier B, Baron JC (1995) PET imaging of neocortical monoaminergic terminals in Parkinson\u2019s disease. J Neural Transm Park Dis Dement Sect 9:55\u201371","journal-title":"J Neural Transm Park Dis Dement Sect"},{"key":"6428_CR31","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1212\/WNL.48.6.1578","volume":"48","author":"M Guttman","year":"1997","unstructured":"Guttman M, Burkholder J, Kish SJ, Hussey D, Wilson A, DaSilva J, Houle S (1997) [11C]RTI-32 PET studies of the dopamine transporter in early dopa-naive Parkinson\u2019s disease: implications for the symptomatic threshold. Neurology 48:1578\u20131583","journal-title":"Neurology"},{"key":"6428_CR32","doi-asserted-by":"crossref","unstructured":"Rinne JO, Laihinen A, Ruottinen H, Ruot- salainen U, N\u00e5gren K, Lehikoinen P, Oikonen V, Rinne UK (1995) Increased density of dopamine D2 receptors in the putamen, but not in the caudate nucleus in early Parkinson\u2019s disease: a PET study with [11C]raclopride. J Neurol Sci 132:156\u2013161","DOI":"10.1016\/0022-510X(95)00137-Q"},{"key":"6428_CR33","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.expneurol.2008.07.021","volume":"214","author":"M Politis","year":"2008","unstructured":"Politis M, Piccini P, Pavese N, Koh SB, Brooks DJ (2008) Evidence of dopamine dysfunction in the hypothalamus of patients with Parkinson\u2019s disease: an in vivo 11C-raclopride PET study. Exp Neurol 214:112\u2013116","journal-title":"Exp Neurol"},{"key":"6428_CR34","first-page":"S6","volume":"43","author":"DJ Brooks","year":"1993","unstructured":"Brooks DJ (1993) PET studies on the early and differential diagnosis of Parkinson\u2019s disease. Neurology 43:S6\u2013S16","journal-title":"Neurology"},{"key":"6428_CR35","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1136\/jnnp.57.3.278","volume":"57","author":"DJ Burn","year":"1994","unstructured":"Burn DJ, Sawle GV, Brooks DJ (1994) Differential diagnosis of Parkinson\u2019s disease, multiple system atrophy, and Steele\u2013Richardson\u2013Olszewski syndrome: discriminant analysis of striatal 18F-dopa PET data. J Neurol Neurosurg Psychiatry 57:278\u2013284","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6428_CR36","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1002\/mds.23135","volume":"25","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Molloy S, Bain GP, Chaudhuri P, Piccini P (2010) Parkinson\u2019s disease symptoms: the patient\u2019s perspective. Mov Disord 25:1646\u20131651","journal-title":"Mov Disord"},{"key":"6428_CR37","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1002\/mds.22473","volume":"24","author":"SH Fox","year":"2009","unstructured":"Fox SH, Chuang R, Brotchie JM (2009) Serotonin and Parkinson\u2019s disease: on movement, mood, and madness. Mov Disord 24:1255\u20131266","journal-title":"Mov Disord"},{"key":"6428_CR38","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.nbd.2010.05.028","volume":"40","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Kiferle L, Molloy S, Brooks DJ, Piccini P (2010) Staging of serotonergic dysfunction in Parkinson\u2019s disease: an in vivo 11C-DASB PET study. Neurobiol Dis 40:216\u2013221","journal-title":"Neurobiol Dis"},{"key":"6428_CR39","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1212\/WNL.0b013e3181feb2ab","volume":"75","author":"M Politis","year":"2010","unstructured":"Politis M, Wu K, Loane C, Turkheimer FE, Molloy S, Brooks DJ, Piccini P (2010) Depressive symptoms in PD correlate with higher 5-HTT binding in raphe and limbic structures. Neurology 75:1920\u20131927","journal-title":"Neurology"},{"key":"6428_CR40","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.nbd.2011.05.009","volume":"43","author":"M Politis","year":"2011","unstructured":"Politis M, Loane C, Wu K, Brooks DJ, Piccini P (2011) Serotonergic mediated body mass index changes in Parkinson\u2019s disease. Neurobiol Dis 43:609\u2013615","journal-title":"Neurobiol Dis"},{"key":"6428_CR41","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O\u2019Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, Djamshidian A, Lees AJ, Piccini P (2011) Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain 134:969\u2013978","journal-title":"Brain"},{"key":"6428_CR42","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1602\/neurorx.1.4.382","volume":"1","author":"O Lindvall","year":"2004","unstructured":"Lindvall O, Bj\u00f6rklund A (2004) Cell therapy in Parkinson\u2019s disease. NeuroRx 1:382\u2013393","journal-title":"NeuroRx"},{"key":"6428_CR43","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/1741-7015-9-50","volume":"9","author":"M Politis","year":"2011","unstructured":"Politis M (2011) Optimizing functional imaging protocols for assessing the outcome of fetal cell transplantation in Parkinson\u2019s disease. BMC Med 9:50","journal-title":"BMC Med"},{"key":"6428_CR44","doi-asserted-by":"crossref","unstructured":"Politis M, Wu K, Loane C, Quinn NP, Brooks DJ, Rehncrona S, Bjorklund A, Lindvall O, Piccini P (2010) Serotonergic neurons mediate dyskinesia side effects in Parkinson\u2019s patients with neural transplants. Sci Transl Med 2:38\u201346","DOI":"10.1126\/scitranslmed.3000976"},{"key":"6428_CR45","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1002\/mds.23743","volume":"26","author":"M Politis","year":"2011","unstructured":"Politis M, Oertel WH, Wu K, Quinn NP, Pogarell O, Brooks DJ, Bjorklund A, Lindvall O, Piccini P (2011) Graft-induced dyskinesias in Parkinson\u2019s disease: high striatal serotonin\/dopamine transporter ratio. Mov Disord 26:1997\u20132003","journal-title":"Mov Disord"},{"key":"6428_CR46","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1741-7015-8-80","volume":"8","author":"M Politis","year":"2010","unstructured":"Politis M (2010) Dyskinesias after neural transplantation in Parkinson\u2019s disease: what do we know and what is next? BMC Med 8:80","journal-title":"BMC Med"},{"key":"6428_CR47","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1093\/brain\/120.3.503","volume":"120","author":"N Ginovart","year":"1997","unstructured":"Ginovart N, Lundin A, Farde L, Halldin C, B\u00e4ckman L, Swahn CG, Pauli S, Sedvall G (1997) PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington\u2019s disease. Brain 120:503\u2013514","journal-title":"Brain"},{"key":"6428_CR48","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/ana.410430216","volume":"43","author":"A Antonini","year":"1998","unstructured":"Antonini A, Leenders KL, Eidelberg D (1998) [11C]raclopride-PET studies of the Huntington\u2019s disease rate of progression: relevance of the trinucleotide repeat length. Ann Neurol 43:253\u2013255","journal-title":"Ann Neurol"},{"key":"6428_CR49","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1093\/brain\/122.12.2353","volume":"122","author":"TC Andrews","year":"1999","unstructured":"Andrews TC, Weeks RA, Turjanski N, Gunn RN, Watkins LH, Sahakian B, Hodges JR, Rosser AE, Wood NW, Brooks DJ (1999) Huntington\u2019s disease progression PET and clinical observations. Brain 122:2353\u20132363","journal-title":"Brain"},{"key":"6428_CR50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1093\/brain\/121.7.1343","volume":"121","author":"AD Lawrence","year":"1998","unstructured":"Lawrence AD, Weeks RA, Brooks DJ, Andrews TC, Watkins LH, Harding AE, Robbins TW, Sahakian BJ (1998) The relationship between striatal dopamine receptor binding and cognitive performance in Huntington\u2019s disease. Brain 121:1343\u20131355","journal-title":"Brain"},{"key":"6428_CR51","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1093\/brain\/awg119","volume":"126","author":"N Pavese","year":"2003","unstructured":"Pavese N, Andrews TC, Brooks DJ, Ho AK, Rosser AE, Barker RA, Robbins TW, Sahakian BJ, Dunnett SB, Piccini P (2003) Progressive striatal and cortical dopamine receptor dysfunction in Huntington\u2019s disease: a PET study. Brain 126:1127\u20131135","journal-title":"Brain"},{"key":"6428_CR52","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.nbd.2009.10.015","volume":"37","author":"N Pavese","year":"2010","unstructured":"Pavese N, Politis M, Tai YF, Barker RA, Tabrizi SJ, Mason SL, Brooks DJ, Piccini P (2010) Cortical dopamine dysfunction in symptomatic and premanifest Huntington\u2019s disease gene carriers. Neurobiol Dis 37:356\u2013361","journal-title":"Neurobiol Dis"},{"key":"6428_CR53","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1212\/01.wnl.0000222734.56412.17","volume":"66","author":"N Pavese","year":"2006","unstructured":"Pavese N, Gerhard A, Tai YF, Ho AK, Turkheimer F, Barker RA, Brooks DJ, Piccini P (2006) Microglial activation correlates with severity in Huntington disease: a clinical and PET study. Neurology 66:1638\u20131643","journal-title":"Neurology"},{"key":"6428_CR54","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1093\/brain\/awm044","volume":"130","author":"YF Tai","year":"2007","unstructured":"Tai YF, Pavese N, Gerhard A, Tabrizi SJ, Barker RA, Brooks DJ, Piccini P (2007) Microglial activation in presymptomatic Huntington\u2019s disease gene carriers. Brain 130:1759\u20131766","journal-title":"Brain"},{"key":"6428_CR55","doi-asserted-by":"crossref","first-page":"2860","DOI":"10.1093\/brain\/awn244","volume":"131","author":"M Politis","year":"2008","unstructured":"Politis M, Pavese N, Tai YF, Tabrizi SJ, Barker RA, Piccini P (2008) Hypothalamic involvement in Huntington\u2019s disease: an in vivo PET study. Brain 131:2860\u20132869","journal-title":"Brain"},{"key":"6428_CR56","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/hbm.21008","volume":"32","author":"M Politis","year":"2011","unstructured":"Politis M, Pavese N, Tai YF, Kiferle L, Mason SL, Brooks DJ, Tabrizi SJ, Barker RA, Piccini P (2011) Microglial activation in regions related to cognitive function predicts disease onset in Huntington\u2019s disease: a multimodal imaging study. Hum Brain Mapp 32:258\u2013270","journal-title":"Hum Brain Mapp"},{"key":"6428_CR57","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1093\/brain\/120.9.1569","volume":"120","author":"RA Weeks","year":"1997","unstructured":"Weeks RA, Ceballos-Baumann A, Piccini P, Boecker H, Harding AE, Brooks DJ (1997) Cortical control of movement in Huntington\u2019s disease, A PET activation study. Brain 120:1569\u20131578","journal-title":"Brain"},{"key":"6428_CR58","first-page":"1591","volume":"42","author":"A Feigin","year":"2001","unstructured":"Feigin A, Leenders KL, Moeller JR, Missimer J, Kuenig G, Spetsieris P, Antonini A, Eidelberg D (2001) Metabolic network abnormalities in early Huntington\u2019s disease: an [(18)F]FDG PET study. J Nucl Med 42:1591\u20131595","journal-title":"J Nucl Med"},{"key":"6428_CR59","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1002\/1531-8249(200005)47:5<644::AID-ANA13>3.0.CO;2-C","volume":"47","author":"G K\u00fcnig","year":"2000","unstructured":"K\u00fcnig G, Leenders KL, Sanchez-Pernaute R, Antonini A, Vontobel P, Verhagen A, G\u00fcnther I (2000) Benzodiazepine receptor binding in Huntington\u2019s disease: [11C]flumazenil uptake measured using positron emission tomography. Ann Neurol 47:644\u2013648","journal-title":"Ann Neurol"},{"key":"6428_CR60","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/ana.20564","volume":"58","author":"S Furtado","year":"2005","unstructured":"Furtado S, Sossi V, Hauser RA, Samii A, Schulzer M, Murphy CB, Freeman TB, Stoessl AJ (2005) Positron emission tomography after fetal transplantation in Huntington\u2019s disease. Ann Neurol 58:331\u2013337","journal-title":"Ann Neurol"},{"key":"6428_CR61","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/brain\/awh003","volume":"127","author":"V Gaura","year":"2004","unstructured":"Gaura V, Bachoud-L\u00e9vi AC, Ribeiro MJ, Nguyen JP, Frouin V, Baudic S, Brugi\u00e8res P, Mangin JF, Boiss\u00e9 MF, Palfi S, Cesaro P, Samson Y, Hantraye P, Peschanski M, Remy P (2004) Striatal neural grafting improves cortical metabolism in Huntington\u2019s disease patients. Brain 127:65\u201372","journal-title":"Brain"},{"key":"6428_CR62","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1468-1331.2010.03154.x","volume":"18","author":"L Kiferle","year":"2011","unstructured":"Kiferle L, Politis M, Muraro PA, Piccini P (2011) Positron emission tomography imaging in multiple sclerosis-current status and future applications. Eur J Neurol 18:226\u2013231","journal-title":"Eur J Neurol"},{"key":"6428_CR63","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.1093\/brain\/123.11.2321","volume":"123","author":"RB Banati","year":"2000","unstructured":"Banati RB, Newcombe J, Gunn RN, Cagnin A, Turkheimer F, Heppner F, Price G, Wegner F, Giovannoni G, Miller DH, Perkin GD, Smith T, Hewson AK, Bydder G, Kreutzberg GW, Jones T, Cuzner ML, Myers R (2000) The peripheral benzodiazepine binding site in the brain in multiple sclerosis: quantitative in vivo imaging of microglia as a measure of disease activity. Brain 123:2321\u20132337","journal-title":"Brain"},{"key":"6428_CR64","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1468-1331.2003.00571.x","volume":"10","author":"JC Debruyne","year":"2003","unstructured":"Debruyne JC, Versijpt J, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, Achten E, Slegers G, Dierckx RA, Korf J, De Reuck JL (2003) PET visualization of microglia in multiple sclerosis patients using [11C]PK11195. Eur J Neurol 10:257\u2013264","journal-title":"Eur J Neurol"},{"key":"6428_CR65","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1191\/1352458505ms1140oa","volume":"11","author":"J Versijpt","year":"2005","unstructured":"Versijpt J, Debruyne JC, Van Laere KJ, De Vos F, Keppens J, Strijckmans K, Achten E, Slegers G, Dierckx RA, Korf J, De Reuck JL (2005) Microglial imaging with positron emission tomography and atrophy measurements with magnetic resonance imaging in multiple sclerosis: a correlative study. Mult Scler 11:127\u2013134","journal-title":"Mult Scler"},{"key":"6428_CR500","doi-asserted-by":"crossref","unstructured":"Politis M, Giannetti P, Su P, Turkheimer F, Keihaninejad S, Wu K, Waldman A, Malik O, Matthews PM, Reynolds R, Nicholas R, Piccini P (2012) Increased PK11195 PET binding in the cortex of MS patients correlates with disability. Neurology (in press)","DOI":"10.1212\/WNL.0b013e3182635645"},{"key":"6428_CR66","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/0022-510X(92)90131-4","volume":"112","author":"C Pozzilli","year":"1992","unstructured":"Pozzilli C, Fieschi C, Perani D, Paulesu E, Comi G, Bastianello S, Bernardi S, Bettinardi V, Bozzao L, Canal N et al (1992) Relationship between corpus callosum atrophy and cerebral metabolic asymmetries in multiple sclerosis. J Neurol Sci 112:51\u201357","journal-title":"J Neurol Sci"},{"key":"6428_CR67","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1006\/nimg.1996.0032","volume":"4","author":"E Paulesu","year":"1996","unstructured":"Paulesu E, Perani D, Fazio F, Comi G, Pozzilli C, Martinelli V, Filippi M, Bettinardi V, Sirabian G, Passafiume D, Anzini A, Lenzi GL, Canal N, Fieschi C (1996) Functional basis of memory impairment in multiple sclerosis: a[18F]FDG PET study. Neuroimage 4:87\u201396","journal-title":"Neuroimage"},{"key":"6428_CR68","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1212\/WNL.48.6.1566","volume":"48","author":"U Roelcke","year":"1997","unstructured":"Roelcke U, Kappos L, Lechner-Scott J, Brunnschweiler H, Huber S, Ammann W, Plohmann A, Dellas S, Maguire RP, Missimer J, Rad\u00fc EW, Steck A, Leenders KL (1997) Reduced glucose metabolism in the frontal cortex and basal ganglia of multiple sclerosis patients with fatigue: a 18F-fluorodeoxyglucose positron emission tomography study. Neurology 48:1566\u20131571","journal-title":"Neurology"},{"key":"6428_CR69","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1212\/WNL.53.1.149","volume":"53","author":"M Blinkenberg","year":"1999","unstructured":"Blinkenberg M, Jensen CV, Holm S, Paulson OB, S\u00f8rensen PS (1999) A longitudinal study of cerebral glucose metabolism, MRI, and disability in patients with MS. Neurology 53:149\u2013153","journal-title":"Neurology"},{"key":"6428_CR70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/BF03164835","volume":"12","author":"X Sun","year":"1998","unstructured":"Sun X, Tanaka M, Kondo S, Okamoto K, Hirai S (1998) Clinical significance of reduced cerebral metabolism in multiple sclerosis: a combined PET and MRI study. Ann Nucl Med 12:89\u201394","journal-title":"Ann Nucl Med"},{"key":"6428_CR71","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/ana.22320","volume":"69","author":"B Stankoff","year":"2011","unstructured":"Stankoff B, Freeman L, Aigrot MS, Chardain A, Doll\u00e9 F, Williams A, Galanaud D, Armand L, Lehericy S, Lubetzki C, Zalc B, Bottlaender M (2011) Imaging central nervous system myelin by positron emission tomography in multiple sclerosis using [methyl-\u00b9\u00b9C]-2-(4\u2032-methylaminophenyl)-6-hydroxybenzothiazole. Ann Neurol 69:673\u2013680","journal-title":"Ann Neurol"},{"key":"6428_CR72","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/00002093-200304000-00002","volume":"17","author":"A Wimo","year":"2003","unstructured":"Wimo A, Winblad B, Aguero-Torres H, von Strauss E (2003) The magnitude of dementia occurrence in the world. Alzheimer Dis Assoc Disord 17:63\u201367","journal-title":"Alzheimer Dis Assoc Disord"},{"key":"6428_CR73","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00259-008-1039-z","volume":"36","author":"L Mosconi","year":"2009","unstructured":"Mosconi L, Mistur R, Switalski R, Tsui WH, Glodzik L, Li Y, Pirraglia E, De Santi S, Reisberg B, Wisniewski T, de Leon MJ (2009) FDG-PET changes in brain glucose metabolism from normal cognition to pathologically verified Alzheimer\u2019s disease. Eur J Nucl Med Mol Imaging 36:811\u2013822","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6428_CR74","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s00259-005-1762-7","volume":"32","author":"L Mosconi","year":"2005","unstructured":"Mosconi L (2005) Brain glucose metabolism in the early and specific diagnosis of Alzheimer\u2019s disease. FDG-PET studies in MCI and AD. Eur J Nucl Med Mol Imaging 32:486\u2013510","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6428_CR75","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1212\/01.wnl.0000269790.05105.16","volume":"69","author":"W Jagust","year":"2007","unstructured":"Jagust W, Reed B, Mungas D, Ellis W, Decarli C (2007) What does fluorodeoxyglucose PET imaging add to a clinical diagnosis of dementia? Neurology 69:871\u2013877","journal-title":"Neurology"},{"key":"6428_CR76","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s13311-010-0012-2","volume":"8","author":"MC Tartaglia","year":"2011","unstructured":"Tartaglia MC, Rosen HJ, Miller BL (2011) Neuroimaging in dementia. Neurotherapeutics 8:82\u201392","journal-title":"Neurotherapeutics"},{"key":"6428_CR77","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1007\/s00259-003-1194-1","volume":"30","author":"A Drzezga","year":"2003","unstructured":"Drzezga A, Lautenschlager N, Siebner H, Riemenschneider M, Willoch F, Minoshima S, Schwaiger M, Kurz A (2003) Cerebral metabolic changes accompanying conversion of mild cognitive impairment into Alzheimer\u2019s disease: a PET follow-up study. Eur J Nucl Med Mol Imaging 30:1104\u20131113","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6428_CR78","first-page":"1625","volume":"46","author":"A Drzezga","year":"2005","unstructured":"Drzezga A, Grimmer T, Riemenschneider M, Lautenschlager N, Siebner H, Alexopoulus P, Minoshima S, Schwaiger M, Kurz A (2005) Prediction of individual clinical outcome in MCI by means of genetic assessment and (18)F-FDG PET. J Nucl Med 46:1625\u20131632","journal-title":"J Nucl Med"},{"key":"6428_CR79","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.exger.2006.05.016","volume":"42","author":"L Mosconi","year":"2007","unstructured":"Mosconi L, Brys M, Glodzik-Sobanska L, De Santi S, Rusinek H, de Leon MJ (2007) Early detection of Alzheimer\u2019s disease using neuroimaging. Exp Gerontol 42:129\u2013138","journal-title":"Exp Gerontol"},{"key":"6428_CR80","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1155\/2009\/609839","volume":"21","author":"GD Rabinovici","year":"2009","unstructured":"Rabinovici GD, Jagust WJ (2009) Amyloid imaging in aging and dementia: testing the amyloid hypothesis in vivo. Behav Neurol 21:117\u2013128","journal-title":"Behav Neurol"},{"key":"6428_CR81","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","volume":"25","author":"JC Price","year":"2005","unstructured":"Price JC, Klunk WE, Lopresti BJ, Lu X, Hoge JA, Ziolko SK, Holt DP, Meltzer CC, DeKosky ST, Mathis CA (2005) Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B. J Cereb Blood Flow Metab 25:1528\u20131547","journal-title":"J Cereb Blood Flow Metab"},{"key":"6428_CR82","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1002\/ana.20889","volume":"60","author":"HA Archer","year":"2006","unstructured":"Archer HA, Edison P, Brooks DJ, Barnes J, Frost C, Yeatman T, Fox NC, Rossor MN (2006) Amyloid load and cerebral atrophy in Alzheimer\u2019s disease: an 11C-PIB positron emission tomography study. Ann Neurol 60:145\u2013147","journal-title":"Ann Neurol"},{"key":"6428_CR83","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1212\/01.wnl.0000240117.55680.0a","volume":"67","author":"NM Kemppainen","year":"2006","unstructured":"Kemppainen NM, Aalto S, Wilson IA, N\u00e5gren K, Helin S, Br\u00fcck A, Oikonen V, Kailaj\u00e4rvi M, Scheinin M, Viitanen M, Parkkola R, Rinne JO (2006) Voxel-based analysis of PET amyloid ligand [11C]PIB uptake in Alzheimer disease. Neurology 67:1575\u20131580","journal-title":"Neurology"},{"key":"6428_CR84","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1212\/01.wnl.0000228230.26044.a4","volume":"67","author":"MA Mintun","year":"2006","unstructured":"Mintun MA, Larossa GN, Sheline YI, Dence CS, Lee SY, Mach RH, Klunk WE, Mathis CA, DeKosky ST, Morris JC (2006) [11C]PIB in a nondemented population: potential antecedent marker of Alzheimer disease. Neurology 67:446\u2013452","journal-title":"Neurology"},{"key":"6428_CR85","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","volume":"31","author":"CC Rowe","year":"2010","unstructured":"Rowe CC, Ellis KA, Rimajova M, Bourgeat P, Pike KE, Jones G, Fripp J, Tochon-Danguy H, Morandeau L, O\u2019Keefe G, Price R, Raniga P, Robins P, Acosta O, Lenzo N, Szoeke C, Salvado O, Head R, Martins R, Masters CL, Ames D, Villemagne VL (2010) Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging. Neurobiol Aging 31:1275\u20131283","journal-title":"Neurobiol Aging"},{"key":"6428_CR86","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.neurobiolaging.2007.03.029","volume":"29","author":"A Forsberg","year":"2008","unstructured":"Forsberg A, Engler H, Almkvist O, Blomquist G, Hagman G, Wall A, Ringheim A, L\u00e5ngstr\u00f6m B, Nordberg A (2008) PET imaging of amyloid deposition in patients with mild cognitive impairment. Neurobiol Aging 29:1456\u20131465","journal-title":"Neurobiol Aging"},{"key":"6428_CR87","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.0b013e3181b23564","volume":"73","author":"A Okello","year":"2009","unstructured":"Okello A, Koivunen J, Edison P, Archer HA, Turkheimer FE, N\u00e5gren K, Bullock R, Walker Z, Kennedy A, Fox NC, Rossor MN, Rinne JO, Brooks DJ (2009) Conversion of amyloid positive and negative MCI to AD over 3 years: an 11C-PIB PET study. Neurology 73:754\u2013760","journal-title":"Neurology"},{"key":"6428_CR88","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/brain\/awq277","volume":"133","author":"CR Jack Jr","year":"2010","unstructured":"Jack CR Jr, Wiste HJ, Vemuri P, Weigand SD, Senjem ML, Zeng G, Bernstein MA, Gunter JL, Pankratz VS, Aisen PS, Weiner MW, Petersen RC, Shaw LM, Trojanowski JQ, Knopman DS, Initiative Alzheimer\u2019s Disease Neuroimaging (2010) Brain beta-amyloid measures and magnetic resonance imaging atrophy both predict time-to-progression from mild cognitive impairment to Alzheimer\u2019s disease. Brain 133:3336\u20133348","journal-title":"Brain"},{"key":"6428_CR89","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/j.neurobiolaging.2008.01.016","volume":"30","author":"T Grimmer","year":"2009","unstructured":"Grimmer T, Henriksen G, Wester HJ, F\u00f6rstl H, Klunk WE, Mathis CA, Kurz A, Drzezga A (2009) Clinical severity of Alzheimer\u2019s disease is associated with PIB uptake in PET. Neurobiol Aging 30:1902\u20131909","journal-title":"Neurobiol Aging"},{"key":"6428_CR90","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.neuropsychologia.2008.02.008","volume":"46","author":"VL Villemagne","year":"2008","unstructured":"Villemagne VL, Pike KE, Darby D, Maruff P, Savage G, Ng S, Ackermann U, Cowie TF, Currie J, Chan SG, Jones G, Tochon-Danguy H, O\u2019Keefe G, Masters CL, Rowe CC (2008) Abeta deposits in older non-demented individuals with cognitive decline are indicative of preclinical Alzheimer\u2019s disease. Neuropsychologia 46:1688\u20131697","journal-title":"Neuropsychologia"},{"key":"6428_CR91","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1136\/jnnp.2007.127878","volume":"79","author":"P Edison","year":"2008","unstructured":"Edison P, Rowe CC, Rinne JO, Ng S, Ahmed I, Kemppainen N, Villemagne VL, O\u2019Keefe G, N\u00e5gren K, Chaudhury KR, Masters CL, Brooks DJ (2008) Amyloid load in Parkinson\u2019s disease dementia and Lewy body dementia measured with [11C]PIB positron emission tomography. J Neurol Neurosurg Psychiatry 79:1331\u20131338","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"6428_CR92","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/j.neuroimage.2007.09.072","volume":"39","author":"W Maetzler","year":"2008","unstructured":"Maetzler W, Reimold M, Liepelt I, Solbach C, Leyhe T, Schweitzer K, Eschweiler GW, Mittelbronn M, Gaenslen A, Uebele M, Reischl G, Gasser T, Machulla HJ, Bares R, Berg D (2008) [11C]PIB binding in Parkinson\u2019s disease dementia. Neuroimage 39:1027\u20131033","journal-title":"Neuroimage"},{"key":"6428_CR93","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.neuroimage.2007.09.020","volume":"39","author":"A Drzezga","year":"2008","unstructured":"Drzezga A, Grimmer T, Henriksen G, Stangier I, Perneczky R, Diehl-Schmid J, Mathis CA, Klunk WE, Price J, DeKosky S, Wester HJ, Schwaiger M, Kurz A (2008) Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer\u2019s disease. Neuroimage 39:619\u2013633","journal-title":"Neuroimage"},{"key":"6428_CR94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s00259-007-0523-1","volume":"35","author":"H Engler","year":"2008","unstructured":"Engler H, Santillo AF, Wang SX, Lindau M, Savitcheva I, Nordberg A, Lannfelt L, L\u00e5ngstr\u00f6m B, Kilander L (2008) In vivo amyloid imaging with PET in frontotemporal dementia. Eur J Nucl Med Mol Imaging 35:100\u2013106","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"6428_CR95","doi-asserted-by":"crossref","first-page":"818","DOI":"10.2967\/jnumed.108.060756","volume":"50","author":"M Koole","year":"2009","unstructured":"Koole M, Lewis DM, Buckley C, Nelissen N, Vandenbulcke M, Brooks DJ, Vandenberghe R, Van Laere K (2009) Whole-body biodistribution and radiation dosimetry of 18F-GE067: a radioligand for in vivo brain amyloid imaging. J Nucl Med 50:818\u2013822","journal-title":"J Nucl Med"},{"key":"6428_CR96","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2967\/jnumed.109.065284","volume":"50","author":"SR Choi","year":"2009","unstructured":"Choi SR, Golding G, Zhuang Z, Zhang W, Lim N, Hefti F, Benedum TE, Kilbourn MR, Skovronsky D, Kung HF (2009) Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. J Nucl Med 50:1887\u20131894","journal-title":"J Nucl Med"},{"key":"6428_CR97","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1474-4422(08)70001-2","volume":"7","author":"CC Rowe","year":"2008","unstructured":"Rowe CC, Ackerman U, Browne W, Mulligan R, Pike KL, O\u2019Keefe G, Tochon-Danguy H, Chan G, Berlangieri SU, Jones G, Dickinson-Rowe KL, Kung HP, Zhang W, Kung MP, Skovronsky D, Dyrks T, Holl G, Krause S, Friebe M, Lehman L, Lindemann S, Dinkelborg LM, Masters CL, Villemagne VL (2008) Imaging of amyloid beta in Alzheimer\u2019s disease with 18F-BAY94-9172, a novel PET tracer: proof of mechanism. Lancet Neurol 7:129\u2013135","journal-title":"Lancet Neurol"},{"key":"6428_CR98","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(01)05625-2","volume":"358","author":"A Cagnin","year":"2001","unstructured":"Cagnin A, Brooks DJ, Kennedy AM, Gunn RN, Myers R, Turkheimer FE, Jones T, Banati RB (2001) In vivo measurement of activated microglia in dementia. Lancet 358:461\u2013467","journal-title":"Lancet"},{"key":"6428_CR99","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1212\/01.wnl.0000338622.27876.0d","volume":"72","author":"A Okello","year":"2009","unstructured":"Okello A, Edison P, Archer HA, Turkheimer FE, Kennedy J, Bullock R, Walker Z, Kennedy A, Fox N, Rossor M, Brooks DJ (2009) Microglial activation and amyloid deposition in mild cognitive impairment: a PET study. Neurology 72:56\u201362","journal-title":"Neurology"},{"key":"6428_CR100","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1001\/archneurol.2008.511","volume":"66","author":"CA Wiley","year":"2009","unstructured":"Wiley CA, Lopresti BJ, Venneti S, Price J, Klunk WE, DeKosky ST, Mathis CA (2009) Carbon 11-labeled Pittsburgh Compound B and carbon 11-labeled (R)-PK11195 positron emission tomographic imaging in Alzheimer disease. Arch Neurol 66:60\u201367","journal-title":"Arch Neurol"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6428-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00415-012-6428-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-012-6428-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,23]],"date-time":"2019-06-23T04:08:22Z","timestamp":1561262902000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00415-012-6428-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,2]]},"references-count":101,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2012,9]]}},"alternative-id":["6428"],"URL":"https:\/\/doi.org\/10.1007\/s00415-012-6428-3","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,2]]}}}